Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.
Home / Multidisciplinary Acute Lymphocytic Leukemia Care / ALL Resources / Critical Insights for Treating Adults with ALL in the Community Webinar

Critical Insights for Treating Adults with ALL in the Community Webinar

Hear critical insights from multidisciplinary cancer team members with expertise in treating older adolescents and adults with acute lymphocytic leukemia (ALL). Using a case-based approach, these experts discuss current treatment strategies for Ph(+) and Ph(-) patients, and take a closer look at the role of minimal residual disease (MRD) for prognosis and treatment selection. Special attention is paid to identification and management of cytokine release syndrome (CRS), along with pertinent drug-drug interactions when using Bcr-Abl tyrosine kinase inhibitors (TKIs) as part of combination treatment. 


Firas El ChaerFiras El Chaer, MD
Hematology and Oncology
Marlene & Stewart Greenebaum Comprehensive Cancer Center
University of Maryland
Baltimore, MD


Robin Dobson, MD Robin Dobson, MD
Hematopathologist; Partner
PBM Labs; Baylor Scott and White Health System
Dallas, TX


Jeff Klaus, PharmD, BCPSJeff Klaus, PharmD, BCPS
Clinical Pharmacy Specialist, Hematologic Malignancies/Hematopoietic Cell Transplantation
Barnes Jewish Hospital
St. Louis, MO

Register for On-Demand Replay

Our Partner

LLS Logo 

Our Supporter

This project is sponsored by Amgen

In the News

Clinical Journals